Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.40
0.00 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
6.44
+0.04 (0.63%)
After-hours: Apr 24, 2026, 5:50 PM EDT

Taysha Gene Therapies Revenue

In the year 2025, Taysha Gene Therapies had annual revenue of $9.77M with 17.28% growth. Taysha Gene Therapies had revenue of $5.49M in the quarter ending December 31, 2025, with 171.27% growth.

Revenue (ttm)
$9.77M
Revenue Growth
+17.28%
P/S Ratio
188.12
Revenue / Employee
$98,717
Employees
99
Market Cap
1.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.77M1.44M17.28%
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Galapagos NV1.31B
Harmony Biosciences Holdings868.45M
Innoviva411.33M
Vericel276.26M
Syndax Pharmaceuticals172.35M
Recursion Pharmaceuticals74.68M
Nurix Therapeutics71.78M
Inhibrx Biosciences1.30M
Revenue Rankings

TSHA News

More News